Нова Зеландия - английски - Ministry for Primary Industries

shandong rainbow international co., limited - epoxiconazole - epoxiconazole 125 g/litre - fungicide

Нова Зеландия - английски - Ministry for Primary Industries

adria new zealand ltd - epoxiconazole - epoxiconazole 125 g/litre - fungicide

Нова Зеландия - английски - Ministry for Primary Industries

agsin pte ltd - epoxiconazole - epoxiconazole 125 g/litre - fungicide

Нова Зеландия - английски - Ministry for Primary Industries

ravensdown limited - epoxiconazole - epoxiconazole 125 g/litre - fungicide

Сингапур - английски - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clarithromycin - granule, for suspension - 125 mg/5 ml - clarithromycin 125 mg/5 ml

Австралия - английски - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - palbociclib, quantity: 125 mg - capsule, hard - excipient ingredients: gelatin; sodium starch glycollate type a; iron oxide yellow; silicon dioxide; magnesium stearate; titanium dioxide; iron oxide red; lactose monohydrate; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; simethicone; ethanol; shellac; sulfuric acid - ibrance is indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with: ? an aromatase inhibitor as initial endocrine-based therapy ? fulvestrant in patients who have received prior therapy.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 125 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; sucrose; hypromellose; poloxamer; gelatin; sodium lauryl sulfate; titanium dioxide; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - palbociclib, quantity: 125 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; silicon dioxide; crospovidone; magnesium stearate; succinic acid; titanium dioxide; hypromellose; triacetin; iron oxide red; indigo carmine aluminium lake - ibrance is indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with: ? an aromatase inhibitor as initial endocrine-based therapy ? fulvestrant in patients who have received prior therapy.

Сингапур - английски - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - cefuroxime axetil - granule, for suspension - 125 mg/5 ml - cefuroxime axetil 125 mg/5 ml

Австралия - английски - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. favic is also indicated for suppression of recurrent genital herpes. favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. favic is also indicated in immunocompromised patients for: - treatment of uncomplicated herpes zoster. - treatment of recurrent herpes simplex. - suppression of recurrent herpes simplex.